This report examines the financial viability of retail pharmacy dispensing operations across a two-year period, evaluating how PBM-dictated rates, MAC pricing compression, and retroactive DIR fee clawbacks collectively erode pharmacy margins - and what contract adjustments are required to restore profitability.